Literature DB >> 5082209

Smoking and warfarin dosage.

A A Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5082209

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Role of tobacco smoking in pharmacokinetics.

Authors:  W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

2.  Pharmacokinetics and pharmacodynamics of warfarin at steady state.

Authors:  P A Routledge; P H Chapman; D M Davies; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

3.  Induction of cytochrome P-448 iso-enzymes and related glucuronyltransferases in the human liver by cigarette smoking.

Authors:  R Fleischmann; H Remmer; U Stärz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Population pharmacokinetics of racemic warfarin in adult patients.

Authors:  D R Mungall; T M Ludden; J Marshall; D W Hawkins; R L Talbert; M H Crawford
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

Review 5.  Interindividual variation and drug interactions with hormonal steroid contraceptives.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

Review 6.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

7.  Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.

Authors:  Babatunde O Sonuga; Derek A Hellenberg; Clint S Cupido; Cilia Jaeger
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-05-31

8.  The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies.

Authors:  Taofik Rusdiana; Yanni D Mardhiani; Norisca A Putriana; Dolih Gozali; Daisuke Nagano; Takuya Araki; Koujirou Yamamoto
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.